Skip to main content
Top
Published in: Surgical Endoscopy 3/2018

01-03-2018

Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1 esophageal cancer? A propensity score-based analysis

Authors: Shengfei Wang, Yangle Huang, Juntao Xie, Lingdun Zhuge, Longlong Shao, Jiaqing Xiang, Yawei Zhang, Yihua Sun, Hong Hu, Sufeng Chen, Toni Lerut, James D. Luketich, Jie Zhang, Haiquan Chen

Published in: Surgical Endoscopy | Issue 3/2018

Login to get access

Abstract

Background

Although endoscopic resection (ER) may be sufficient treatment for early-stage esophageal cancer, additional treatment is recommended when there is a high risk of cancer recurrence. It is unclear whether delaying esophagectomy by performing and assessing the success of ER affects outcomes as compared with immediate esophagectomy without ER. Additionally, long-term survival after sequential ER and esophagectomy required further investigation.

Methods

Between 2011 and 2015, 48 patients with stage T1 esophageal cancer underwent esophagectomy after ER with curative intent at our institution. Two-to-one propensity score methods were used to identify 96 matched-control patients who were treated with esophagectomy only using baseline patient, tumor characteristics and surgical approach. Time from initial evaluation to esophagectomy, relapse-free survival, overall survival, and postoperative complications were compared between the propensity-matched groups.

Results

In the ER + esophagectomy group, the time from initial evaluation to esophagectomy was significantly longer than in the esophagectomy only group (114 vs. 8 days, p < 0.001). The incidence of dense adhesion (p = 0.347), operative time (p = 0.867), postoperative surgical complications (p = 0.966), and postoperative length of hospital stay (p = 0.125) were not significantly different between the groups. Moreover, recurrence-free survival and overall survival were also similar between the two groups (p = 0.411 and p = 0.817, respectively).

Conclusions

Treatment of stage T1 esophageal cancer with ER prior to esophagectomy did not increase the difficulty of performing esophagectomy or the incidence of postoperative complications and did not affect survival after esophagectomy. These results suggest that ER can be recommended for patients with stage T1 cancer even if esophagectomy is warranted eventually.
Literature
1.
go back to reference Wang GQ, Jiao GG, Chang FB, Fang WH, Song JX, Lu N, Lin DM, Xie YQ, Yang L (2004) Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Ann Thorac Surg 77(5):1740–1744CrossRefPubMed Wang GQ, Jiao GG, Chang FB, Fang WH, Song JX, Lu N, Lin DM, Xie YQ, Yang L (2004) Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Ann Thorac Surg 77(5):1740–1744CrossRefPubMed
2.
go back to reference Pech O, Bollschweiler E, Manner H, Leers J, Ell C, Holscher AH (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 254(1):67–72CrossRefPubMed Pech O, Bollschweiler E, Manner H, Leers J, Ell C, Holscher AH (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 254(1):67–72CrossRefPubMed
3.
go back to reference Kim DU, Lee JH, Min BH, Shim SG, Chang DK, Kim YH, Rhee PL, Kim JJ, Rhee JC, Kim KM, Shim YM (2008) Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma. J Gastroenterol Hepatol 23(4):619–625CrossRefPubMed Kim DU, Lee JH, Min BH, Shim SG, Chang DK, Kim YH, Rhee PL, Kim JJ, Rhee JC, Kim KM, Shim YM (2008) Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma. J Gastroenterol Hepatol 23(4):619–625CrossRefPubMed
4.
go back to reference Spechler SJ (2015) Dysplasia in Barrett’s esophagus: limitations of current management strategies. Am J Gastroenterol 100(4):927–935CrossRef Spechler SJ (2015) Dysplasia in Barrett’s esophagus: limitations of current management strategies. Am J Gastroenterol 100(4):927–935CrossRef
5.
go back to reference Pech O, May A, Gossner L, Rabenstein T, Manner H, Huijsmans J, Vieth M, Stolte M, Berres M, Ell C (2007) Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy 39(1):30–35CrossRefPubMed Pech O, May A, Gossner L, Rabenstein T, Manner H, Huijsmans J, Vieth M, Stolte M, Berres M, Ell C (2007) Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy 39(1):30–35CrossRefPubMed
6.
go back to reference Das A, Singh V, Fleischer DE, Sharma VK (2008) A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol 103(6):1340–1345CrossRefPubMed Das A, Singh V, Fleischer DE, Sharma VK (2008) A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol 103(6):1340–1345CrossRefPubMed
7.
go back to reference Nealis TB, Washington K, Keswani RN (2011) Endoscopic therapy of esophageal premalignancy and early malignancy. J Natl Compr Cancer Netw: JNCCN 9(8):890–899CrossRef Nealis TB, Washington K, Keswani RN (2011) Endoscopic therapy of esophageal premalignancy and early malignancy. J Natl Compr Cancer Netw: JNCCN 9(8):890–899CrossRef
8.
go back to reference Choi JY, Park YS, Jung HY, Ahn JY, Kim MY, Lee JH, Choi KS, Kim do H, Choi KD, Song HJ, Lee GH, Cho KJ, Kim JH (2011) Feasibility of endoscopic resection in superficial esophageal squamous carcinoma. Gastrointest Endosc 73(5):881–889CrossRefPubMed Choi JY, Park YS, Jung HY, Ahn JY, Kim MY, Lee JH, Choi KS, Kim do H, Choi KD, Song HJ, Lee GH, Cho KJ, Kim JH (2011) Feasibility of endoscopic resection in superficial esophageal squamous carcinoma. Gastrointest Endosc 73(5):881–889CrossRefPubMed
9.
go back to reference Park JS, Youn YH, Park JJ, Kim JH, Park H (2016) Clinical outcomes of endoscopic submucosal dissection for superficial esophageal squamous neoplasms. Clin Endosc 49(2):168–175CrossRefPubMedPubMedCentral Park JS, Youn YH, Park JJ, Kim JH, Park H (2016) Clinical outcomes of endoscopic submucosal dissection for superficial esophageal squamous neoplasms. Clin Endosc 49(2):168–175CrossRefPubMedPubMedCentral
10.
go back to reference Qin X, He S, Zhang Y, Xue L, Lu N, Wang G (2014) Diagnosis and staging of superficial esophageal precursor based on pre-endoscopic resection system comparable to endoscopic resection. BMC Cancer 14:774CrossRefPubMedPubMedCentral Qin X, He S, Zhang Y, Xue L, Lu N, Wang G (2014) Diagnosis and staging of superficial esophageal precursor based on pre-endoscopic resection system comparable to endoscopic resection. BMC Cancer 14:774CrossRefPubMedPubMedCentral
11.
go back to reference Merkow RP, Bilimoria KY, Keswani RN, Chung J, Sherman KL, Knab LM, Posner MC, Bentrem DJ (2014) Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. J Natl Cancer Inst 106(7):dju133CrossRefPubMed Merkow RP, Bilimoria KY, Keswani RN, Chung J, Sherman KL, Knab LM, Posner MC, Bentrem DJ (2014) Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. J Natl Cancer Inst 106(7):dju133CrossRefPubMed
12.
go back to reference Davison JM, Landau MS, Luketich JD, McGrath KM, Foxwell TJ, Landsittel DP, Gibson MK, Nason KS et al (2016) A model based on pathologic features of superficial esophageal adenocarcinoma complements clinical node staging in determining risk of metastasis to lymph nodes. Clin Gastroenterol Hepatol 14(3):369–377CrossRefPubMed Davison JM, Landau MS, Luketich JD, McGrath KM, Foxwell TJ, Landsittel DP, Gibson MK, Nason KS et al (2016) A model based on pathologic features of superficial esophageal adenocarcinoma complements clinical node staging in determining risk of metastasis to lymph nodes. Clin Gastroenterol Hepatol 14(3):369–377CrossRefPubMed
13.
go back to reference Pech O, May A, Manner H, Behrens A, Pohl J, Weferling M, Hartmann U, Manner N, Huijsmans J, Gossner L, Rabenstein T, Vieth M, Stolte M, Ell C et al (2014) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146(3):652–660CrossRefPubMed Pech O, May A, Manner H, Behrens A, Pohl J, Weferling M, Hartmann U, Manner N, Huijsmans J, Gossner L, Rabenstein T, Vieth M, Stolte M, Ell C et al (2014) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146(3):652–660CrossRefPubMed
14.
go back to reference Gertler R, Stein HJ, Schuster T, Rondak IC, Höfler H, Feith M et al (2014) Prevalence and topography of lymph node metastases in early esophageal and gastric cancer. Ann Surg 259(1):96–101CrossRefPubMed Gertler R, Stein HJ, Schuster T, Rondak IC, Höfler H, Feith M et al (2014) Prevalence and topography of lymph node metastases in early esophageal and gastric cancer. Ann Surg 259(1):96–101CrossRefPubMed
15.
go back to reference Participants in the Paris Workshop (2003) The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 58 (6 Suppl): S3–S43 Participants in the Paris Workshop (2003) The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 58 (6 Suppl): S3–S43
16.
go back to reference Van Westreenen HL, Westerterp M, Bossuyt PM, Pruim J, Sloof GW, van Lanschot JJ, Groen H, Plukker JT (2004) Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 22(18):3805–3812CrossRefPubMed Van Westreenen HL, Westerterp M, Bossuyt PM, Pruim J, Sloof GW, van Lanschot JJ, Groen H, Plukker JT (2004) Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 22(18):3805–3812CrossRefPubMed
17.
go back to reference Lightdale CJ, Kulkarni KG (2005) Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol 23(20):4483–4489CrossRefPubMed Lightdale CJ, Kulkarni KG (2005) Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol 23(20):4483–4489CrossRefPubMed
18.
go back to reference Eguchi T, Nakanishi Y, Shimoda T, Iwasaki M, Igaki H, Tachimori Y, Kato H, Yamaguchi H, Saito D, Umemura S (2006) Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Modern Pathol 19(3):475–480CrossRef Eguchi T, Nakanishi Y, Shimoda T, Iwasaki M, Igaki H, Tachimori Y, Kato H, Yamaguchi H, Saito D, Umemura S (2006) Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Modern Pathol 19(3):475–480CrossRef
19.
go back to reference Ciocirlan M, Lapalus MG, Hervieu V, Souquet JC, Napoleon B, Scoazec JY, Lefort C, Saurin JC, Ponchon T (2007) Endoscopic mucosal resection for squamous premalignant and early malignant lesions of the esophagus. Endoscopy 39(1):24–29CrossRefPubMed Ciocirlan M, Lapalus MG, Hervieu V, Souquet JC, Napoleon B, Scoazec JY, Lefort C, Saurin JC, Ponchon T (2007) Endoscopic mucosal resection for squamous premalignant and early malignant lesions of the esophagus. Endoscopy 39(1):24–29CrossRefPubMed
20.
go back to reference NCCN Clinical Practice Guidelines in Oncology: Esophageal and Esophagogastric Junction Cancers. http://www.nccn.org. Version 1.2017. Updated March 21, 2017. Accessed 1 June 2017 NCCN Clinical Practice Guidelines in Oncology: Esophageal and Esophagogastric Junction Cancers. http://​www.​nccn.​org. Version 1.2017. Updated March 21, 2017. Accessed 1 June 2017
21.
go back to reference Tomita N, Matsumoto T, Hayashi T, Arakawa A, Sonoue H, Kajiyama Y, Tsurumaru M (2008) Lymphatic invasion according to D2-40 immunostaining is a strong predictor of nodal metastasis in superficial squamous cell carcinoma of the esophagus: algorithm for risk of nodal metastasis based on lymphatic invasion. Pathol Int 58(5):282–287CrossRefPubMed Tomita N, Matsumoto T, Hayashi T, Arakawa A, Sonoue H, Kajiyama Y, Tsurumaru M (2008) Lymphatic invasion according to D2-40 immunostaining is a strong predictor of nodal metastasis in superficial squamous cell carcinoma of the esophagus: algorithm for risk of nodal metastasis based on lymphatic invasion. Pathol Int 58(5):282–287CrossRefPubMed
22.
go back to reference Sgourakis G, Gockel I, Lang H (2013) Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review. World J Gastroenterol 19(9):1424–1437CrossRefPubMedPubMedCentral Sgourakis G, Gockel I, Lang H (2013) Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review. World J Gastroenterol 19(9):1424–1437CrossRefPubMedPubMedCentral
23.
go back to reference Holscher AH (2007) Endoscopic mucosal resection for early squamous-cell cancer of the esophagus–a dangerous game or standard treatment? Endoscopy 39(1):77–79PubMed Holscher AH (2007) Endoscopic mucosal resection for early squamous-cell cancer of the esophagus–a dangerous game or standard treatment? Endoscopy 39(1):77–79PubMed
24.
go back to reference Badreddine RJ, Prasad GA, Lewis JT, Lutzke LS, Borkenhagen LS, Dunagan KT, Wang KK (2010) Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma. Clin Gastroenterol Hepatol 8(3):248–253CrossRefPubMed Badreddine RJ, Prasad GA, Lewis JT, Lutzke LS, Borkenhagen LS, Dunagan KT, Wang KK (2010) Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma. Clin Gastroenterol Hepatol 8(3):248–253CrossRefPubMed
25.
go back to reference Ono S, Fujishiro M, Niimi K, Goto O, Kodashima S, Yamamichi N, Omata M (2009) Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc 70(5):860–866CrossRefPubMed Ono S, Fujishiro M, Niimi K, Goto O, Kodashima S, Yamamichi N, Omata M (2009) Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc 70(5):860–866CrossRefPubMed
26.
go back to reference Takahashi H, Arimura Y, Masao H, Okahara S, Tanuma T, Kodaira J, Kagaya H, Shimizu Y, Hokari K, Tsukagoshi H, Shinomura Y, Fujita M (2010) Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 72(2):255–264CrossRefPubMed Takahashi H, Arimura Y, Masao H, Okahara S, Tanuma T, Kodaira J, Kagaya H, Shimizu Y, Hokari K, Tsukagoshi H, Shinomura Y, Fujita M (2010) Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 72(2):255–264CrossRefPubMed
27.
go back to reference Okada K, Tsuchida T, Ishiyama A, Taniguchi T, Suzuki S, Horiuchi Y, Matsuo Y, Yoshizawa N, Suganuma T, Omae M, Kubota M, Hirasawa T, Yamamoto Y, Inamori M, Yamamoto N, Nakajima A (2012) Endoscopic mucosal resection and endoscopic submucosal dissection for en bloc resection of superficial pharyngeal carcinomas. Endoscopy 44(6):556–564CrossRefPubMed Okada K, Tsuchida T, Ishiyama A, Taniguchi T, Suzuki S, Horiuchi Y, Matsuo Y, Yoshizawa N, Suganuma T, Omae M, Kubota M, Hirasawa T, Yamamoto Y, Inamori M, Yamamoto N, Nakajima A (2012) Endoscopic mucosal resection and endoscopic submucosal dissection for en bloc resection of superficial pharyngeal carcinomas. Endoscopy 44(6):556–564CrossRefPubMed
28.
go back to reference Tang B, Bai JY, Zhao XY, Fan CQ, Yang X, Deng L, Yang SM, Yu J (2015) Endoscopic submucosal dissection for superficial esophageal cancer with near-circumferential lesions: our experience with 40 patients. Surg Endosc 29(8):2141–2148CrossRefPubMed Tang B, Bai JY, Zhao XY, Fan CQ, Yang X, Deng L, Yang SM, Yu J (2015) Endoscopic submucosal dissection for superficial esophageal cancer with near-circumferential lesions: our experience with 40 patients. Surg Endosc 29(8):2141–2148CrossRefPubMed
Metadata
Title
Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1 esophageal cancer? A propensity score-based analysis
Authors
Shengfei Wang
Yangle Huang
Juntao Xie
Lingdun Zhuge
Longlong Shao
Jiaqing Xiang
Yawei Zhang
Yihua Sun
Hong Hu
Sufeng Chen
Toni Lerut
James D. Luketich
Jie Zhang
Haiquan Chen
Publication date
01-03-2018
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 3/2018
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-017-5830-4

Other articles of this Issue 3/2018

Surgical Endoscopy 3/2018 Go to the issue